Analysts are expecting this healthcare tech company to grow by 16.53% annually for the next five years.
Cerner Corporation (CERN)
From PAD System Report
Cerner has rallied further to 70, its highest price in many months. The company reported a so-so third quarter, but did log a gain over the previous year. Value Line projects that Cerner’s earnings per share growth will accelerate sharply over the next year. The company is strong financially, and is in the right industry: health care cost control. R+D is almost 12% of revenues. Our only concern now is that the stock price has reached the low end of its 3-5 year appreciation potential.
Daniel A. Seiver, PAD System Report, www.padsystemreport.com, Dept. of Finance, S.D.S.U, San Diego, CA 92181, December 2, 2017